Oceania Healthcare

Rising Costs Will Constrain Elderly Care While Modest Recovery Emerges

AnalystLowTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

30 Aug 25

AnalystLowTarget's Fair Value

NZ$0.73

2.7% undervalued

04 Sep

NZ$0.71

-11.3%

7.6%

-11.3%

7.6%

Edit anytime before Aug 30 10:19 PM. Then post Updates to your followers.

Author's Valuation

NZ$0.7

2.7% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

NZ$0.7

2.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.28%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.60%

Calculation

NZ$74.03m

Earnings '28

8.89x

PE Ratio '28

NZ$657.88m

Market Cap '28

NZ$657.88m

Market Cap '28

724.46m

No. shares '28

NZ$0.91

Share Price '28

NZ$0.91 Share Price '28

Discounted to 2025 @ 7.57% p.a.

NZ$0.73

Fair Value '25